| Released | Contributor | Author | Title | Pages | Price |
|---|
| May 19, 2013 | Market Edge | N/A | Market Edge Equity Research Report | 4 | $10 | | May 17, 2013 | Pechala's Reports | Frantisek Pechala | ARNA PHARMACEUTICALS INC (ARNA) 12-months forecast | 1 | $15 | | May 16, 2013 | New Constructs, LLC | N/A | ARNA: Due Diligence Review: Forensic Earnings and Valuation | 13 | $25 | | May 16, 2013 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for Medical-biomed/genetics | 18 | $207 | | May 16, 2013 | Ford Investor Services, Inc. | N/A | Industry Value Graph: ARNA , CTIC , CGEN , VPHM -- DRUGS | 3 | $34.50 | | May 16, 2013 | Ford Investor Services, Inc. | N/A | Value Graph: ARENA PHARMACEUT -- ARNA | 1 | $11.50 | | May 15, 2013 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for ARNA | 11 | $126.50 | | May 12, 2013 | Alpha Street Research | Hunter Orr | ARNA - Arena Pharmaceuticals Inc - Downgraded to a Sell - Company Analysis and ASR Ranking Report | 9 | $24 | | May 12, 2013 | Pechala's Reports | Lubomir Pechala | ARNA PHARMACEUTICALS INC (ARNA) - REPORT FOR ACTIVE TRADERS | 1 | $25 | | May 10, 2013 | S&P Capital IQ Quantitative Report | N/A | Arena Pharmaceuticals | 6 | $69 |
|
View All Reports for ARNA ... |
|
|
0.02(0.25%) May 17, 4:00PM EDT|After Hours
:
8.00